China Zhong Qi Hldgs Ltd.の将来のP / EはN/Aです。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
024 Pharma, Inc. provides healthcare products worldwide. Its products include vitamin and mineral supplements; stress release, joint, heart health, and weight-loss products; and skin care, hair, and anti-aging products. The company was formerly known as B Green Innovations, Inc. and changed its name to 024 Pharma, Inc. in October 2016. 024 Pharma, Inc. was incorporated in 2004 and is based in West Palm Beach, Florida.